Clinical Outcomes of Ruxolitinib in the Salvage Treatment of Chronic Graft-Versus-Host Disease

被引：0
|
作者：
Ji, Yanping [1 ]
Tang, Baolin [2 ]
Zhu, Xiaoyu [2 ]
Liu, Huilan [2 ]
Song, Kaidi [2 ]
Wan, Xiang [2 ]
Yao, Wen [2 ]
Sun, Guangyu [2 ]
Wang, Jian [3 ]
Sun, Zimin [2 ]
机构：
[1] Anhui Med Univ, Anhui Prov Hosp, Hefei, Peoples R China
[2] Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, Hefei, Peoples R China
[3] Univ Sci & Technol China, Anhui Prov Hosp, Hefei, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130138
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5677
引用
收藏
页数：3
相关论文
共 50 条
  • [41] THALIDOMIDE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
    HENEY, D
    NORFOLK, DR
    WHEELDON, J
    BAILEY, CC
    LEWIS, IJ
    BARNARD, DL
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (01) : 23 - 27
  • [42] Treatment of chronic graft-versus-host disease in 2011
    Inamoto, Yoshihiro
    Flowers, Mary E. D.
    CURRENT OPINION IN HEMATOLOGY, 2011, 18 (06) : 414 - 420
  • [43] Treatment of chronic graft-versus-host disease with bortezomib
    Pai, Chien-Chun Steven
    Chen, Mingyi
    Mirsoian, Annie
    Grossenbacher, Steven K.
    Tellez, Joseph
    Ames, Erik
    Sun, Kai
    Jagdeo, Jared
    Blazar, Bruce R.
    Murphy, William J.
    Abedi, Mehrdad
    BLOOD, 2014, 124 (10) : 1677 - 1688
  • [44] THALIDOMIDE FOR THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE
    VOGELSANG, GB
    FARMER, ER
    HESS, AD
    ALTAMONTE, V
    BESCHORNER, WE
    JABS, DA
    CORIO, RL
    LEVIN, LS
    COLVIN, OM
    WINGARD, JR
    SANTOS, GW
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (16): : 1055 - 1058
  • [45] Hydroxychloroquine for the treatment of chronic graft-versus-host disease
    Gilman, AL
    Chan, KW
    Mogul, M
    Morris, C
    Goldman, FD
    Boyer, M
    Cirenza, E
    Mazumder, A
    Gehan, E
    Cahill, R
    Frankel, S
    Schultz, K
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (3A) : 327 - 334
  • [46] Early Outcomes of Ruxolitinib in the Treatment of Steroid Refractory Graft-versus-host Disease on Liver Transplant Recipients
    Kakadia, Sunilkumar
    Trotta, Holly
    Kurczek, Leslie
    Burdine, Lyle
    Veeraputhiran, Muthu
    Giorgakis, Emmanouil
    TRANSPLANTATION, 2020, 104 (08) : E247 - E247
  • [47] Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease
    Assouan, Deborah
    Lebon, Delphine
    Charbonnier, Amandine
    Royer, Bruno
    Marolleau, Jean-Pierre
    Gruson, Berengere
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (05) : 687 - 689
  • [48] Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease
    Abedin, Sameem M.
    Hamadani, Mehdi
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (05) : 423 - 427
  • [49] Treatment of steroid-refractory acute and chronic graft-versus-host disease with ruxolitinib in adults and children
    Moiseev, Ivan
    Morozova, Elena
    Barabanshikova, Maria
    Kozlov, Andrey
    Rudakova, Tatyana
    Klimova, Olesya
    Tcvetkov, Nikolai
    Pirogova, Olga
    Borzenkova, Evgeniya
    Kozhokar, Polina
    Ekushev, Kirill
    Paina, Olesya
    Bykova, Tatyana
    Darskaya, Elena
    Bondarenko, Sergey
    Zubarovskaya, Ludmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2018, 53 : 461 - 462
  • [50] Results of four regimes of salvage treatment of refractory chronic graft-versus-host disease (GVHD).
    Sullivan, KM
    Flowers, MED
    Nims, J
    Leisenring, W
    Siadak, M
    Witherspoon, R
    Deeg, HJ
    Sanders, J
    Anasetti, C
    Thompson, D
    Appelbaum, FR
    Storb, R
    BLOOD, 1996, 88 (10) : 2564 - 2564
12345